These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 29476014)

  • 1. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 2. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
    Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
    Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA Receptor Autoantibodies in Autoimmune Encephalitis Cause a Subunit-Specific Nanoscale Redistribution of NMDA Receptors.
    Ladépêche L; Planagumà J; Thakur S; Suárez I; Hara M; Borbely JS; Sandoval A; Laparra-Cuervo L; Dalmau J; Lakadamyali M
    Cell Rep; 2018 Jun; 23(13):3759-3768. PubMed ID: 29949761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.
    Hughes EG; Peng X; Gleichman AJ; Lai M; Zhou L; Tsou R; Parsons TD; Lynch DR; Dalmau J; Balice-Gordon RJ
    J Neurosci; 2010 Apr; 30(17):5866-75. PubMed ID: 20427647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive Allosteric Modulation of NMDARs Prevents the Altered Surface Dynamics Caused by Patients' Antibodies.
    Maudes E; Jamet Z; Marmolejo L; Dalmau JO; Groc L
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200261. PubMed ID: 38771989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies.
    Steinke S; Kirmann T; Loi EA; Nerlich J; Weichard I; Kuhn P; Bullmann T; Ritzau-Jost A; Rizalar FS; Prüss H; Haucke V; Geis C; Hust M; Hallermann S
    Brain; 2023 May; 146(5):1812-1820. PubMed ID: 36866449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
    Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE
    Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
    Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
    Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Derived Anti-NMDAR Antibody Disinhibits Cortical Neuronal Networks through Dysfunction of Inhibitory Neuron Output.
    Andrzejak E; Rabinovitch E; Kreye J; Prüss H; Rosenmund C; Ziv NE; Garner CC; Ackermann F
    J Neurosci; 2022 Apr; 42(15):3253-3270. PubMed ID: 35241491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.
    Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D
    J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis.
    Moscato EH; Peng X; Jain A; Parsons TD; Dalmau J; Balice-Gordon RJ
    Ann Neurol; 2014 Jul; 76(1):108-19. PubMed ID: 24916964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity.
    Hubalkova P; Ladislav M; Vyklicky V; Smejkalova T; Hrcka Krausova B; Kysilov B; Krusek J; Naimová Z; Korinek M; Chodounska H; Kudova E; Cerny J; Vyklicky L
    J Neurosci; 2021 Mar; 41(10):2119-2134. PubMed ID: 33526476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Methyl-D-Aspartate Receptor Antibodies in Autoimmune Encephalopathy Alter Oligodendrocyte Function.
    Matute C; Palma A; Serrano-Regal MP; Maudes E; Barman S; Sánchez-Gómez MV; Domercq M; Goebels N; Dalmau J
    Ann Neurol; 2020 May; 87(5):670-676. PubMed ID: 32052483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Kinase C-Mediated Phosphorylation and α2δ-1 Interdependently Regulate NMDA Receptor Trafficking and Activity.
    Zhou MH; Chen SR; Wang L; Huang Y; Deng M; Zhang J; Zhang J; Chen H; Yan J; Pan HL
    J Neurosci; 2021 Jul; 41(30):6415-6429. PubMed ID: 34252035
    [No Abstract]   [Full Text] [Related]  

  • 15. Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.
    Jiang XY; Lei S; Zhang L; Liu X; Lin MT; Blumcke I; Piao YS; Zhou D; Li JM
    Acta Neuropathol Commun; 2020 Aug; 8(1):130. PubMed ID: 32771066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
    Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autoimmune encephalitis-update: roles of autoantibodies in the pathogenesis].
    Tanaka K
    Rinsho Shinkeigaku; 2014; 54(12):1107-9. PubMed ID: 25672721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents.
    Korinek M; Sedlacek M; Cais O; Dittert I; Vyklicky L
    Neuroscience; 2010 Feb; 165(3):736-48. PubMed ID: 19883737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential.
    Geoffroy C; Paoletti P; Mony L
    J Physiol; 2022 Jan; 600(2):233-259. PubMed ID: 34339523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.